Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Pharmacy Business Models topic
No spam. Unsubscribe anytime.
Committee advances draft definitions for outpatient pharmacy business models, seeks revisions on specialty, mail‑order and PIC roles
Summary
Members reviewed draft definitions for chain, independent, health‑system, mail‑order and specialty pharmacies; stakeholders raised concerns about overlap, a 75% home‑delivery threshold for mail order, the role of the pharmacist‑in‑charge in self‑assessment, and potential payer/PBM misuse — committee will refine language for the full board.
The licensing committee reviewed a lengthy draft that would define outpatient pharmacy business models — including chain community pharmacy, independent community pharmacy, health‑system pharmacy, mail‑order pharmacy, specialty pharmacy, closed‑door and related categories — and discussed how those definitions would support future targeted exemptions or tailored regulatory requirements.
Members voiced three recurring concerns: (1) overlapping classifications may create ambiguity (for example, a health‑system pharmacy that operates 75 or more sites could qualify as both a health‑system and a chain community pharmacy); (2) giving the pharmacist in charge (PIC) responsibility for self‑determining the business model via a self‑assessment could produce inconsistent outcomes across similar operations; and (3) defining specialty pharmacy by "high cost" alone could be imprecise and create unintended consequences if payers or PBMs used the board’s taxonomy to reclassify pharmacies for reimbursement or network participation.
Industry commenters urged clearer standards and explained operational realities. Danny Addison, speaking for CVS Pharmacy, said the draft needs clearer implementation rules: "placing the responsibility on the pharmacist in charge to determine applicable business models via self assessment could create some inconsistency even within the same company." (Danny Addison, CVS)
John Gray, representing Kaiser Permanente, asked the committee to consider whether long‑standing regulatory obligations that apply to retail chain pharmacies (such as staffing or quota‑style rules) are appropriate for integrated, non‑profit health system pharmacies, and urged the committee to think about different operational motivations when crafting exemptions.
Members discussed possible fixes: adding a "medium chain" or regional category for chains with 5–74 stores, tying specialty pharmacy criteria to commonly used programmatic signals (limited distribution, REMS requirements or third‑party accreditations) rather than a pure cost threshold, and strengthening the rule language that clarifies these definitions are for regulatory classification only and not intended for payer network determinations. Several members asked staff and counsel to draft stronger protective language so third parties cannot repurpose the definitions for contracting or reimbursement decisions.
Next steps: Staff will revise the draft definitions (including consideration of a medium‑chain category, removing or refining a cost‑based specialty definition, and clarifying the PIC role and non‑interference language) and present amended language to the full board for further deliberation.
